CID 168354695

Vardenafil metabolite 1

Structural Information

Molecular Formula
C21H30N6O3S
SMILES
CCCC1=NC(=C2N1NC(=NC2)C3=C(C=CC(=C3)S(=O)(=O)N4CCNCC4)OCC)C
InChI
InChI=1S/C21H30N6O3S/c1-4-6-20-24-15(3)18-14-23-21(25-27(18)20)17-13-16(7-8-19(17)30-5-2)31(28,29)26-11-9-22-10-12-26/h7-8,13,22H,4-6,9-12,14H2,1-3H3,(H,23,25)
InChIKey
LHZACQMUBIBSTD-UHFFFAOYSA-N
Compound name
2-(2-ethoxy-5-piperazin-1-ylsulfonylphenyl)-5-methyl-7-propyl-1,4-dihydroimidazo[5,1-f][1,2,4]triazine
Related CIDs

2D Structure

compound 2d structure
1
Annotation Hits

0
References

0
Patents

446.21002 Da
Monoisotopic Mass

1.4
XlogP (predicted)

Profile

Predicted Collision Cross Section

Adduct m/z Predicted CCS (Ų)
[M+H]+ 447.21730 210.3
[M+Na]+ 469.19924 216.7
[M-H]- 445.20274 210.2
[M+NH4]+ 464.24384 213.2
[M+K]+ 485.17318 208.7
[M+H-H2O]+ 429.20728 200.2
[M+HCOO]- 491.20822 212.2
[M+CH3COO]- 505.22387 215.0
[M+Na-2H]- 467.18469 207.6
[M]+ 446.20947 209.1
[M]- 446.21057 209.1
m/z: mass to charge ratio of the adduct.
Predicted Collision Cross Section (CCS) values (Ų) per adduct calculated using CCSbase.

Literature stripe

literature stripe

Patent stripe

No patent data available for this compound.